0001415889-25-008166.txt : 20250314 0001415889-25-008166.hdr.sgml : 20250314 20250314213506 ACCESSION NUMBER: 0001415889-25-008166 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250312 FILED AS OF DATE: 20250314 DATE AS OF CHANGE: 20250314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Marcus Gail Boxer CENTRAL INDEX KEY: 0001702176 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 25742107 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-03142025_090301.xml X0508 4 2025-03-12 0001604821 Natera, Inc. NTRA 0001702176 Marcus Gail Boxer C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 true false false false 1 Common Stock 2025-03-12 4 M 0 4000 7.86 A 13704 D Common Stock 2025-03-12 4 S 0 1014 145.8644 D 12690 D Common Stock 2025-03-12 4 S 0 923 147.2016 D 11767 D Common Stock 2025-03-12 4 S 0 1682 148.7078 D 10085 D Common Stock 2025-03-12 4 S 0 381 149.2733 D 9704 D Stock Option (right to buy) 7.86 2025-03-12 4 M 0 4000 0 D 2027-04-16 Common Stock 4000 1130 D .The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2024. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.53 to $146.29 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.8050 to $147.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.10 to $149.0905 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.1826 to $149.4859 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares are fully exercisable. /s/ Tami Chen, Attorney-in-Fact 2025-03-14